Abstract
The prevalence of substance use among older adults aged 65 and older is increasing with great significance. The use of alcohol, tobacco, and illicit drugs coupled with increasing misuse of prescription medications in the elderly presents new challenges for providers of this population. Diagnosis of various substance use disorders should also be taken with special consideration in older adults given potential changes in physiology, cognitive functioning, and social roles. Treatment of older adults with substance use disorders can be pharmacologic or non-pharmacologic, depending on the patient’s needs. While there are several means and methods of identifying and treating substance use, much of the research and pharmacologic treatment options for older adult populations has been with alcohol use disorders. Non-pharmacologic and therapeutic treatment for various substance use disorders can be useful options in older adults as well. There is limited published research on substance use in older adults, and continued efforts to better measure this mounting public health problem and develop age-specific and culturally appropriate treatments and interventions are needed to ensure optimal health outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schulden J, Lopez M, Compton W. Clinical implications of drug abuse epidemiology. Psychiatr Clin North Am. 2012;35(2):411–23. https://doi.org/10.1016/j.psc.2012.03.007.Clinical.
Ortman J, Velkoff V, Hogan H. An aging nation: the older population in the United States. Current population reports. http://www.census.gov/library/publications/2014/demo/p25-1140.html. Published 2014. Accessed 5 April 2016.
Reynolds K, Pietrzak RH, El-Gabalawy R, Mackenzie CS, Sareen J. Prevalence of psychiatric disorders in U. S. older adults: findings from a nationally representative survey. World Psychiatry. 2015;14(1):74–81. https://doi.org/10.1002/wps.20193.
Han B, Gfroerer J, Colliver J, Penne M. Substance use disorder among older adults in the United States in 2020. Addiction. 2009;104(1):88–96.
Gfroerer J, Penne M, Pemberton M, Folsom R. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2003;69(2):127–35.
Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers -- United States, 1999-2008. Morb Mortal Wkly Rep. 2011;60(43):1487–92.
Blazer DG, Wu L-T. The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults national survey on drug use and health. Psychiatry Interpers Biol Process. 2011;166(10):1162–9. https://doi.org/10.1176/appi.ajp.2009.09010016.
U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMSHA). Results from the 2013 national survey on drug use and health: summary of national findings. Rockville, MD; 2013.
Oslin D. Late-life alcoholism: issues relevant to the geriatric psychiatrist. Am J Geriatr Psychiatry. 2004;12(6):571–83.
Lynskey M, Day C, Hall W. Alcohol and other drug use disorders among older-aged people. Drug Alcohol Rev. 2003;22(2):125–33.
Barnes AJ, Moore AA, Xu H, et al. Prevalence and correlates of at-risk drinking among older adults: the project SHARE study. J Gen Intern Med. 2010;25(8):840–6. https://doi.org/10.1007/s11606-010-1341-x.
Dinitto DM, Choi NG. Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and implications for intervention. Int Psychogeriatr. 2011;23(5):732–41. https://doi.org/10.1017/S1041610210002176.
Blazer DG, Wu L-T. The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health (NSDUH). Am J Geriatr Psychiatry. 2009;17(3):237–45. https://doi.org/10.1097/JGP.0b013e318190b8ef.
Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629–54. https://doi.org/10.1016/j.cger.2014.04.008.
ProCon.org. 24 legal medical marijuana states and DC. Medical marijuana home. http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881. Published 2004. Accessed 1 Jan 2016.
Rimer BK, Orleans CT. Tailoring smoking cessation for older adults. Cancer. 1994;74(7 Suppl):2051–4.
Li-Tzy W, Blazer DG. Illicit and nonmedical drug use among older adults: a review. J Aging Health. 2011;23(3):481–504. https://doi.org/10.1177/0898264310386224.Illicit.
Kuo YF, Raji MA, Chen NW, Hasan H, Goodwin JS. Trends in opioid prescriptions among part D medicare recipients from 2007 to 2012. Am J Med. 2015;129(221):21–30. https://doi.org/10.1016/j.amjmed.2015.10.002.
Simoni-Wastila L, Yang H. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother. 2006;4(4):380–94.
Kalapatapu RK, Sullivan MA. Prescription use disorders in older adults. Am J Addict. 2010;19(6):515–22. https://doi.org/10.1111/j.1521-0391.2010.00080.x.
Becker W, Tobin D, Feillin D. Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates. Arch Intern Med. 2011;171(11):1034–5.
Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration. Treatment episode data set (TEDS). April 2016. http://wwwdasis.samhsa.gov/webt/quicklink/US13.htm. Published 2013. Accessed 1 April 2016.
Volkow N, Warren K. Drug addiction: the neurobiology of behavior gone awry. In: Ries RK, Fiellin DA, Miller SC, Saitz R, editors. The ASAM principles of addiction medicine. Fifth ed. Beijing: Wolters Kluwer; 2014. p. 4–5.
Moeller FG. Drug abuse and dependence. In: Nabel E, Federman D, editors. Scientific American medicine. Hamilton, ON: Decker Intellectual Properties; 2016. p. 1–16. https://doi.org/10.2310/7900.1191.
Mavandadi S, Oslin D. Substance-related and addictive disorders. In: Steffens D, Blazer D, Thakur M, editors. The American psychiatric publishing textbook of geriatric psychiatry. 5th ed. Arlington, VA: American Psychiatric Publishing; 2015.
Ries RK, Fiellin DA, Miller SC, Saitz R. American Society for addiction medicine principles of addiction medicine. 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2014.
Mulsant BH, Pollock BG. Psychopharmacology. In: Thakur ME, Blazer DG, Steffens DC, editors. Clinical manual of geriatric psychiatry. 1st ed. Washington, D.C.: American Psychiatric Publishing; 2014. p. 17–82.
American Psychiatric Association. American Psychiatric Association: diagnostic and statistical manual of mental disorders. 5th ed. (American Psychiatric Association, ed.). Arlington, VA: American Psychiatric Publishing; 2013.
Angelica MD, Fong Y. Substance abuse among older adults. 2008;141(4):520–529. https://doi.org/10.1016/j.surg.2006.10.010.Use.
Koechl B, Unger A, Fischer G. Age-related aspects of addiction. Gerontology. 2012;58(6):540–4. https://doi.org/10.1159/000339095.Age-related.
Mcinnes E, Powell J. Drug and alcohol referrals : are elderly substance abuse diagnoses and referrals being missed ? Br Med J. 1994;308(6926):444–6.
Gilson AM, Kreis PG. The burden of the nonmedical use of prescription opioid analgesics. Pain Med. 2009;10(S2):S89–S100. https://doi.org/10.1111/j.1526-4637.2009.00668.x.
NIAAA. Alcohol and your health. National Institute on Alcohol Abuse and Alcoholism. https://www.niaaa.nih.gov/alcohol-health/special-populations-co-occurring-disorders/older-adults. Published 2014. Accessed 1 April 2016.
Adams W, Barry K, Flemin M. Screening for problem drinking in older primary care patients. J Am Med Assoc. 1996;276(24):1964–7.
O’Connell H, Chin A, Hamilton F, et al. A systematic review of the utility of self-report alcohol screening instruments in the elderly. Int J Geriatr Psychiatry. 2004;19(11):1074–86.
GĂ³mez A, Conde A, Santana JM, JorrĂn A, Serrano IM, Medina R. The diagnostic usefulness of AUDIT and AUDIT-C for detecting hazardous drinkers in the elderly. Aging Ment Health. 2006;10(5):558–61. https://doi.org/10.1080/13607860600637729.
Piccinelli M, Tessari E, Bortolomasi M, et al. Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. BMJ. 1997;314(7078):420–4.
Kan CC, Breteler MH, van der Ven AH, Zitman FG. Cross-validation of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Compr Psychiatry. 2001;42(5):433–9. https://doi.org/10.1053/comp.2001.26275.
de las Cuevas C, Sanz EJ, de La Fuente JA, Padilla J, Berenguer JC. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction. 2000;95(2000):245–50.
Voyer P, Roussel ME, Berbiche D, Préville M. Effectively detect dependence on benzodiazepines among community-dwelling seniors by asking only two questions. J Psychiatr Ment Health Nurs. 2010;17(4):328–34. https://doi.org/10.1111/j.1365-2850.2009.01529.x.
Arndt S, Clayton R, Schultz S. Trends in substance abuse treatment 1998-2008: increasing older adult first time admissions for illicit drugs. Am J Geriatr Psychiatry. 2011;19(8):704–11.
Oslin D, Pettinati H, Volpicelli J. Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes. Am J Geriatr Psychiatry. 2002;10(6):740–7.
Oslin D, Slaymaker V, Blow F, Owen P, Colleran C. Treatment outcomes for alcohol dependence among middle-aged and older adults. Addict Behav. 2005;30(7):1431–6.
Jonas D, Garbutt J, Amick H, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2012;157(9):645–54.
Kuerbis A, Sacco P. A review of existing treatments for substance abuse among the elderly and recommendations for future directions. Subst Abuse. 2013;7:13–37.
Alcoholics Anonymous, edoitors. Twelve steps and twelve traditions. New York: Alcoholics Anonymous; 2004.
Schonfeld L, King-Kallimanis BL, Duchene DM, et al. Screening and brief intervention for substance misuse among older adults: the Florida BRITE project. Am J Public Health. 2010;100(1):108–14. https://doi.org/10.2105/AJPH.2008.149534.
Ayalon L, Jin C, Mcculloch CE, et al. Integrated specialty mental health care among older minorities improves access but not outcomes: results of the PRISMe study. Int J Geriatr Psychiatry. 2008;23(August):1086–92. https://doi.org/10.1002/gps.
Barry K, Blow F. Drinking over the lifespan. Alcohol Res. 2016;38(1):115–20.
Ramesh D, Haney M. Treatment of cannabis use disorders. In: Textbook of addiction treatment: international perspectives; 2015. P. 367–380. https://doi.org/10.1007/978-88-470-5322-9_14.
Ryrie I. Motivational interviewing. In: Norman I, Ryrie I, editors. The art and science of mental health nursing: principles and practice; 2013. P. 356–366.
Petrovic M, Vandierendonck A, Mariman A, Van Maele G, Afschrift M, Pevernagie D. Personality traits and socio-epidemiological status of hospitalised elderly benzodiazepine users. Int J Geriatr Psychiatry. 2002;17(8):733–8.
Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8. https://doi.org/10.1001/jamainternmed.2014.949.
Caputo F, Vignoli T, Leggio L, Addolorato G, Zoli G, Bernardi M. Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. Exp Gerontol. 2012;47(6):411–6. https://doi.org/10.1016/j.exger.2012.03.019.
Letizia M, Reinbolz M. Identifying and managing acute alcohol withdrawal in the elderly. Geriatr Nurs. 2005;26:176–83.
Stahl S. Stahl’s essential psychopharmacology - prescriber's guide. 5th ed. New York: Cambridge University Press; 2014.
Substance Abuse and Mental Health Services Administration. Incorporating alcohol pharmacotherapies into medical practice treatment improvement protocol (TIP) series, no. 49. Rockville, MD; 2009.
Litten R, Wilford B, Falk D, Ryan M, Fertig J. Potential medications for the treatment of alcohol use disorder: an evaluation of clinical efficacy and safety. Subst Abus. 2016;37(2):286–98.
Berlin R, Butler P, Perloff M. Gabapentin therapy in psychiatric disorders: a systematic review. Prim Care Companion CNS Disord. 2015;17(5). https://doi.org/10.4088/PCC.15r01821.
Cawkwell PB, Blaum C, Sherman SE. Pharmacological smoking cessation. Drugs Aging. 2015;32(6):443–51.
Hartmann-Boyce J, Aveyard P. Drug for smoking cessation. Br Med J. 2016;352(571):1–5.
Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(8):622–34. https://doi.org/10.7326/M15-2023.
Tannenbaum MD, MSc C. Inappropriate benzodiazepine use in elderly patients and its reduction. J Psychiatry Neurosci. 2015;40(3):E27–8. https://doi.org/10.1503/jpn.140355.
Shorter D, Kosten TR. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011;9(1):119. https://doi.org/10.1186/1741-7015-9-119.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Maree, R.D., Riccelli, C.A. (2018). Substance-Related and Addictive Disorders. In: Tampi, R., Tampi, D., Boyle, L. (eds) Psychiatric Disorders Late in Life. Springer, Cham. https://doi.org/10.1007/978-3-319-73078-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-73078-3_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73076-9
Online ISBN: 978-3-319-73078-3
eBook Packages: MedicineMedicine (R0)